Phoenix Financial’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Sell
17,500
-5,033
-22% -$118K ﹤0.01% 358
2026
Q1
$337K Hold
22,533
– – ﹤0.01% 361
2025
Q4
$328K Sell
22,533
-11,679
-34% -$204K ﹤0.01% 368
2025
Q3
$614K Buy
34,212
+8,929
+35% +$131K 0.01% 270
2025
Q2
$431K Sell
25,283
-6,911
-21% -$69.2K 0.01% 298
2025
Q1
$234K Buy
32,194
+5,450
+20% +$62K ﹤0.01% 328
2024
Q4
$376K Buy
26,744
+8,790
+49% +$130K 0.01% 288
2024
Q3
$213K Buy
+17,954
New +$186K ﹤0.01% 334

Other funds holding CORZ

Phoenix Financial's CORZ Position: Q2 2026 in Review

Phoenix Financial reduced its Core Scientific (CORZ) stake by 22% in Q2 2026, selling an estimated $118K and leaving 17,500 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #358.

Phoenix Financial first reported a position in CORZ in Q3 2024 and has held it in 8 quarters since. The position peaked at $614K in Q3 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Phoenix Financial held 17,500 shares of Core Scientific worth $446K as of Q2 2026.
  • Phoenix Financial sold 5,033 Core Scientific shares in Q2 2026, an estimated $118K.
  • Core Scientific made up ﹤0.01% of Phoenix Financial's portfolio in Q2 2026, its #358 holding.
  • Phoenix Financial first reported a position in Core Scientific in Q3 2024 and has held it in 8 quarters since.
  • Phoenix Financial's Core Scientific position peaked at $614K in Q3 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.